| Trevo System: Single-Center Experience with a Novel Mechanical Thrombectomy Device. | |
| | |
MedLine Citation:
|
PMID: 22211809 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND AND PURPOSE: Recent reports have indicated that mechanical thrombectomy may have the potential to treat acute ischemic stroke. This study aims to describe the safety and effectiveness of Trevo Retriever, using Stentriever technology, in revascularization of patients with acute ischemic stroke. METHODS: Prospective study evaluating the clinical, radiological, and functional outcome of 13 patients with an angiographically verified occlusion of the anterior cerebral circulation. All patients underwent thrombectomy with TR as monotherapy or in combination with intra-arterial thrombolysis, within the first 8 hours from the onset of symptoms. Successful revascularization was defined as thrombolysis in cerebral ischemia grade 2a to 3. Good outcome was defined as modified Rankin Scale score ≤ 2. RESULTS: Median baseline National Institutes of Health Stroke Scale score was 19(16-22). The occlusion site was middle cerebral artery in 8 patients and internal carotid artery in 5 patients. Revascularization was achieved in 10 of 13 patients (77%). The mean time from groin puncture to recanalization was 95 ± 31 minutes. No significant intra-procedural complications occurred. Four patients (30%) died during the 90-day follow-up period and 4 patients (30%) achieved functional independence. CONCLUSION: Early clinical experience suggests that the TR can allow safe and effective revascularization in certain subjects with acute ischemic stroke. J Neuroimaging 2011;XX:1-5. |
| | |
Authors:
|
Nuno Mendonça; Alan Flores; Jorge Pagola; Marta Rubiera; David Rodríguez-Luna; M Angels De Miquel; Pere Cardona; Helena Quesada; Paloma Mora; José Alvarez-Sabín; Carlos Molina; Marc Ribó |
Related Documents
:
|
7598379 - Autologous secondary breast augmentation with pedicled transverse rectus abdominis musc... 22142779 - Chads(2)- and cha(2)ds(2)vasc scores and embolic risk in left ventricular hypertrabecul... 21447109 - Clinical profiles of late-onset semantic dementia, compared with early-onset semantic d... 8614039 - Lower limb trauma with injury to the popliteal vessels. 22456429 - Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. 16698909 - Prognostic factors of leg amputation in patients with vascular injury: a systematic rev... 8191619 - Beta 2-microglobulin amyloidosis: illustrative cases. 18430269 - Systemic sclerosis prevalence and comorbidities in the us, 2001-2002. 8815159 - Neurological impairment and recovery in wilson's disease: evidence from pet and mri. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-30 |
Journal Detail:
|
Title: Journal of neuroimaging : official journal of the American Society of Neuroimaging Volume: - ISSN: 1552-6569 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2012-1-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9102705 Medline TA: J Neuroimaging Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 by the American Society of Neuroimaging. |
Affiliation:
|
From the Department of Neurology, University Hospital of Coimbra, Coimbra, Portugal (NM); Stroke Unit, Department of Neurosciences, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (AF, JP, MR, DRL, JAS, CM, MR); Neuroradiología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain (MADM, PM); Servicio de Neurología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain (PC, HQ). |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effector and scaffolding proteins AF6 and MUPP1 interact with connexin36 and localize at gap jun...
Next Document: Newcastle Disease Virus: a Promising Agent for Tumor Immunotherapy.